MeSH D012532 - scabies
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ivermectin | Ivermectin | 2019-09-13 | |||
| Padagis | Ivermectin | Ivermectin | 2020-04-13 | |||
| Permethrin | Permethrin | 2003-04-21 | ||||
| Taro Pharmaceutical | Ivermectin | Ivermectin | 2020-05-06 | |||
| Perrigo | Permethrin | Permethrin | 2001-12-20 | |||
| GSK | Permethrin | Nix | 1986-03-31 | |||
| Merck & Co | Ivermectin | Stromectol | 1996-11-22 | |||
| Aurobindo Pharma | Permethrin | Elimite | 1989-08-25 | |||
| Zydus Therapeutics | Ivermectin | Ivermectin | 2022-08-02 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
67%2/3
Phase 3
71%10/14
Approved: 6Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use